In the present study, we examine the therapeutic ability of CFZ combined with CPT-11 in vitro and in vivo by evaluating the effect on CRC tumor growth, cell proliferation, cell cycle progression, apoptosis, migration and invasion, as well as on NF-κB regulated pathways. Here, NFKB1 is linked to neoplasm.